Adriana Teixeira

2.4k total citations
18 papers, 452 citations indexed

About

Adriana Teixeira is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Adriana Teixeira has authored 18 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Adriana Teixeira's work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Adriana Teixeira is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Adriana Teixeira collaborates with scholars based in Portugal, Brazil and Italy. Adriana Teixeira's co-authors include Tânia Beatriz Creczynski‐Pasa, Vânia Rodrigues de Lima, Clarissa Amorim Silva de Cordova, Joan Bladé, Paolo Corradini, Meletios Α. Dimopoulos, Pilar Giraldo, Johannes Drach, Maria Teresa Petrucci and Igor Wolfgang Blau and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Lancet Oncology.

In The Last Decade

Adriana Teixeira

17 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adriana Teixeira Portugal 10 167 122 121 82 78 18 452
Manabu Matsunawa Japan 9 135 0.8× 67 0.5× 70 0.6× 150 1.8× 31 0.4× 22 401
Ewa Gloc Poland 9 230 1.4× 61 0.5× 156 1.3× 29 0.4× 14 0.2× 15 608
Zuanel Diaz Canada 13 283 1.7× 135 1.1× 104 0.9× 26 0.3× 26 0.3× 21 605
J S Lazo United States 13 322 1.9× 171 1.4× 96 0.8× 36 0.4× 200 2.6× 19 789
A. Yu. Grishanova Russia 12 172 1.0× 122 1.0× 13 0.1× 22 0.3× 56 0.7× 66 486
Eric B. Harstad United States 15 238 1.4× 170 1.4× 12 0.1× 63 0.8× 153 2.0× 21 653
Dimitra J. Mitsiou Greece 14 388 2.3× 103 0.8× 15 0.1× 52 0.6× 64 0.8× 26 738
Omar S. Khan United States 9 283 1.7× 81 0.7× 16 0.1× 43 0.5× 63 0.8× 12 527
Byung-Eun Kim United States 7 245 1.5× 190 1.6× 47 0.4× 71 0.9× 140 1.8× 7 662
Supriya Chakraborty India 12 159 1.0× 39 0.3× 10 0.1× 60 0.7× 40 0.5× 20 370

Countries citing papers authored by Adriana Teixeira

Since Specialization
Citations

This map shows the geographic impact of Adriana Teixeira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriana Teixeira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriana Teixeira more than expected).

Fields of papers citing papers by Adriana Teixeira

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriana Teixeira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriana Teixeira. The network helps show where Adriana Teixeira may publish in the future.

Co-authorship network of co-authors of Adriana Teixeira

This figure shows the co-authorship network connecting the top 25 collaborators of Adriana Teixeira. A scholar is included among the top collaborators of Adriana Teixeira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriana Teixeira. Adriana Teixeira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Almeida‐Santos, Teresa, et al.. (2016). Recomendações para a preservação do potencial reprodutivo no doente oncológico.. Estudo Geral (Universidade de Coimbra). 2(1). 5–24. 6 indexed citations
2.
Ferreira, Wallax Augusto Silva, Adriana Teixeira, Rommel Mário Rodríguez Burbano, et al.. (2016). An Update on the Epigenetics of Glioblastomas. Epigenomics. 8(9). 1289–1305. 21 indexed citations
3.
Esteves, Susana, Manuel Guerreiro, Inês Amorim Monteiro Barbosa, et al.. (2014). What Determines Therapeutic Choices for Elderly Patients With DLBCL? Clinical Findings of a Multicenter Study in Portugal. Clinical Lymphoma Myeloma & Leukemia. 14(5). 370–379. 8 indexed citations
4.
Petrucci, Maria Teresa, Pilar Giraldo, Paolo Corradini, et al.. (2013). A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma. British Journal of Haematology. 160(5). 649–659. 96 indexed citations
5.
Sarmento‐Ribeiro, Ana Bela, Teresa Proença, Isabel Sousa, et al.. (2012). A possible role for oxidation stress in lymphoid leukaemias and therapeutic failure. Leukemia Research. 36(8). 1041–1048. 14 indexed citations
6.
Crump, M., Adriana Scheliga, Jiří Mayer, et al.. (2011). Efficacy and safety of bortezomib-rituximab (VCR) vs rituximab® in patients (PTS) with relapsed, R-naive/-sensitive follicular lymphoma (FL): outcome according to prior therapy. Annals of Oncology. 22. 186–186. 1 indexed citations
7.
Kimby, Eva, Adriana Scheliga, Jiří Mayer, et al.. (2011). FCGR3A polymorphism does not significantly affect response and outcome of follicular lymphoma patients treated in the PRIMA study with rituximab and chemotherapy followed by rituximab maintenance or observation. Annals of Oncology. 22. 187–187. 1 indexed citations
8.
Coiffier, Bertrand, Evgenii A. Osmanov, Xiaonan Hong, et al.. (2011). Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial. The Lancet Oncology. 12(8). 773–784. 81 indexed citations
9.
10.
Carvalho, Susana, Marília Brito Gomes, Paulo Lúcio, et al.. (2010). Análise económica do rituximab, em associação com ciclofosfamida, vincristina e prednisolona no tratamento de doentes com linfoma folicular avançado em Portugal. Repositório Comum (Repositório Científico de Acesso Aberto de Portugal).
11.
Coiffier, Bertrand, Evgenii A. Osmanov, Xiaonan Hong, et al.. (2010). A Phase 3 Trial Comparing Bortezomib Plus Rituximab with Rituximab Alone In Patients with Relapsed, Rituximab-Naive or -Sensitive, Follicular Lymphoma. Blood. 116(21). 857–857. 11 indexed citations
12.
Barroso, Sérgio, José Dinis, João F. Lacerda, et al.. (2009). Biossimilares em oncologia.. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Barroso, Sérgio, José Dinis, João F. Lacerda, et al.. (2009). [Biosimilars in oncology].. PubMed. 22(3). 203–6. 1 indexed citations
14.
Petrucci, Maria Teresa, Igor W. Blau, Paolo Corradini, et al.. (2009). Efficacy and Safety of Retreatment with Bortezomib in Patients with Multiple Myeloma: Interim Results From RETRIEVE, a Prospective International Phase 2 Study.. Blood. 114(22). 3866–3866. 9 indexed citations
15.
Petrucci, Maria Teresa, Igor Wolfgang Blau, Paolo Corradini, et al.. (2008). Efficacy and Safety of Re-Treatment with Bortezomib (Velcade©) in Patients with Multiple Myeloma: Results from a Prospective International Phase II Trial. Blood. 112(11). 3690–3690. 9 indexed citations
16.
Franco, Jeferson Luís, Adriana Teixeira, Flávia Carla Meotti, et al.. (2006). Cerebellar thiol status and motor deficit after lactational exposure to methylmercury. Environmental Research. 102(1). 22–28. 83 indexed citations
17.
Lima, Vânia Rodrigues de, et al.. (2004). Relationship between the action of reactive oxygen and nitrogen species on bilayer membranes and antioxidants. Chemistry and Physics of Lipids. 132(2). 197–208. 28 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manabu Matsunawa Breakdown of academic impact, for papers by Ewa Gloc Breakdown of academic impact, for papers by Zuanel Diaz Breakdown of academic impact, for papers by J S Lazo Breakdown of academic impact, for papers by A. Yu. Grishanova Breakdown of academic impact, for papers by Eric B. Harstad Breakdown of academic impact, for papers by Dimitra J. Mitsiou Breakdown of academic impact, for papers by Omar S. Khan Breakdown of academic impact, for papers by Byung-Eun Kim Breakdown of academic impact, for papers by Supriya Chakraborty
Rankless by CCL
2026